Annual Operating Profit
-$78.20 M
-$90.38 M-742.24%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual operaing income is currently -$78.20 million, with the most recent change of -$90.38 million (-742.24%) on 31 December 2023. During the last 3 years, it has fallen by -$6.68 million (-9.34%). ARCT annual operating profit is now -742.24% below its all-time high of $12.18 million, reached on 31 December 2022.ARCT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$10.74 M
+$10.39 M+49.18%
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly operating income is currently -$10.74 million, with the most recent change of +$10.39 million (+49.18%) on 30 September 2024. Over the past year, it has increased by +$8.58 million (+44.41%). ARCT quarterly operating profit is now -108.84% below its all-time high of $121.45 million, reached on 31 December 2022.ARCT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$80.55 M
+$8.58 M+9.62%
30 September 2024
Summary:
Arcturus Therapeutics Holdings TTM operating income is currently -$80.55 million, with the most recent change of +$8.58 million (+9.62%) on 30 September 2024. Over the past year, it has dropped by -$142.07 million (-230.93%). ARCT TTM operating profit is now -204.19% below its all-time high of $77.31 million, reached on 31 March 2023.ARCT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -742.2% | +44.4% | -230.9% |
| 3 y3 years | -9.3% | +80.0% | +59.0% |
| 5 y5 years | -258.6% | -41.0% | -422.8% |
ARCT Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -742.2% | +61.5% | -108.8% | +80.6% | -204.2% | +60.3% |
| 5 y | 5 years | -742.2% | +61.5% | -108.8% | +81.4% | -204.2% | +60.3% |
| alltime | all time | -742.2% | +61.5% | -108.8% | +81.4% | -204.2% | +60.3% |
Arcturus Therapeutics Holdings Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.74 M(-49.2%) | -$80.55 M(-9.6%) |
| June 2024 | - | -$21.13 M(-30.5%) | -$89.12 M(-27.8%) |
| Mar 2024 | - | -$30.41 M(+66.4%) | -$123.37 M(+57.8%) |
| Dec 2023 | -$78.20 M(-742.2%) | -$18.27 M(-5.4%) | -$78.20 M(-227.1%) |
| Sept 2023 | - | -$19.31 M(-65.1%) | $61.52 M(+39.7%) |
| June 2023 | - | -$55.37 M(-475.3%) | $44.03 M(-43.1%) |
| Mar 2023 | - | $14.76 M(-87.9%) | $77.31 M(+534.9%) |
| Dec 2022 | $12.18 M(-106.0%) | $121.45 M(-430.0%) | $12.18 M(-108.3%) |
| Sept 2022 | - | -$36.81 M(+66.6%) | -$146.92 M(-10.4%) |
| June 2022 | - | -$22.09 M(-56.2%) | -$163.93 M(-16.2%) |
| Mar 2022 | - | -$50.38 M(+33.8%) | -$195.56 M(-3.6%) |
| Dec 2021 | -$202.85 M(+183.6%) | -$37.65 M(-30.1%) | -$202.85 M(+3.3%) |
| Sept 2021 | - | -$53.82 M(+0.2%) | -$196.29 M(+20.1%) |
| June 2021 | - | -$53.72 M(-6.8%) | -$163.41 M(+36.5%) |
| Mar 2021 | - | -$57.67 M(+85.5%) | -$119.73 M(+67.4%) |
| Dec 2020 | -$71.52 M(+180.3%) | -$31.08 M(+48.4%) | -$71.52 M(+39.5%) |
| Sept 2020 | - | -$20.94 M(+108.5%) | -$51.26 M(+35.1%) |
| June 2020 | - | -$10.04 M(+6.1%) | -$37.94 M(+33.3%) |
| Mar 2020 | - | -$9.46 M(-12.5%) | -$28.47 M(+11.6%) |
| Dec 2019 | -$25.51 M(+17.0%) | -$10.82 M(+42.0%) | -$25.51 M(+65.6%) |
| Sept 2019 | - | -$7.62 M(+1231.5%) | -$15.41 M(+26.8%) |
| June 2019 | - | -$572.00 K(-91.2%) | -$12.15 M(-43.9%) |
| Mar 2019 | - | -$6.51 M(+815.3%) | -$21.65 M(-0.8%) |
| Dec 2018 | -$21.81 M | -$711.00 K(-83.7%) | -$21.81 M(-16.3%) |
| Sept 2018 | - | -$4.36 M(-56.8%) | -$26.07 M(+5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$10.07 M(+51.0%) | -$24.82 M(+56.9%) |
| Mar 2018 | - | -$6.67 M(+34.3%) | -$15.82 M(+23.8%) |
| Dec 2017 | -$10.49 M(+949.2%) | -$4.97 M(+59.6%) | -$12.78 M(-224.5%) |
| Sept 2017 | - | -$3.11 M(+192.0%) | $10.26 M(+88.3%) |
| June 2017 | - | -$1.07 M(-70.7%) | $5.45 M(+810.0%) |
| Mar 2017 | - | -$3.63 M(-120.1%) | $599.00 K(-159.9%) |
| Dec 2016 | -$1.00 M(-47.7%) | $18.07 M(-328.1%) | -$1.00 M(-84.0%) |
| Sept 2016 | - | -$7.92 M(+33.9%) | -$6.26 M(+135.3%) |
| June 2016 | - | -$5.92 M(+13.1%) | -$2.66 M(+38.9%) |
| Mar 2016 | - | -$5.23 M(-140.8%) | -$1.92 M(+0.2%) |
| Dec 2015 | -$1.91 M(-94.2%) | $12.81 M(-396.4%) | -$1.91 M(-91.1%) |
| Sept 2015 | - | -$4.32 M(-16.4%) | -$21.55 M(-22.5%) |
| June 2015 | - | -$5.17 M(-1.1%) | -$27.81 M(-8.7%) |
| Mar 2015 | - | -$5.23 M(-23.4%) | -$30.47 M(-7.9%) |
| Dec 2014 | -$33.08 M(+221.5%) | -$6.83 M(-35.5%) | -$33.08 M(+3.7%) |
| Sept 2014 | - | -$10.59 M(+35.2%) | -$31.89 M(+30.5%) |
| June 2014 | - | -$7.83 M(-0.1%) | -$24.45 M(+37.3%) |
| Mar 2014 | - | -$7.83 M(+38.8%) | -$17.81 M(+73.1%) |
| Dec 2013 | -$10.29 M(+585.5%) | -$5.64 M(+80.0%) | -$10.29 M(+110.2%) |
| Sept 2013 | - | -$3.14 M(+162.2%) | -$4.89 M(+142.0%) |
| June 2013 | - | -$1.20 M(+280.9%) | -$2.02 M(+61.1%) |
| Mar 2013 | - | -$314.00 K(+26.1%) | -$1.26 M(+33.3%) |
| Dec 2012 | -$1.50 M(-61.6%) | -$249.00 K(-5.7%) | -$942.00 K(+35.9%) |
| Sept 2012 | - | -$264.00 K(-38.5%) | -$693.00 K(+61.5%) |
| June 2012 | - | -$429.00 K | -$429.00 K |
| Dec 2011 | -$3.91 M | - | - |
FAQ
- What is Arcturus Therapeutics Holdings annual operaing income?
- What is the all time high annual operating profit for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual operating profit year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly operating income?
- What is the all time high quarterly operating profit for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly operating profit year-on-year change?
- What is Arcturus Therapeutics Holdings TTM operating income?
- What is the all time high TTM operating profit for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings TTM operating profit year-on-year change?
What is Arcturus Therapeutics Holdings annual operaing income?
The current annual operating profit of ARCT is -$78.20 M
What is the all time high annual operating profit for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual operaing income is $12.18 M
What is Arcturus Therapeutics Holdings annual operating profit year-on-year change?
Over the past year, ARCT annual operaing income has changed by -$90.38 M (-742.24%)
What is Arcturus Therapeutics Holdings quarterly operating income?
The current quarterly operating profit of ARCT is -$10.74 M
What is the all time high quarterly operating profit for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly operating income is $121.45 M
What is Arcturus Therapeutics Holdings quarterly operating profit year-on-year change?
Over the past year, ARCT quarterly operating income has changed by +$8.58 M (+44.41%)
What is Arcturus Therapeutics Holdings TTM operating income?
The current TTM operating profit of ARCT is -$80.55 M
What is the all time high TTM operating profit for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high TTM operating income is $77.31 M
What is Arcturus Therapeutics Holdings TTM operating profit year-on-year change?
Over the past year, ARCT TTM operating income has changed by -$142.07 M (-230.93%)